The recent jump in US borrowing costs is driving a fresh wave of net investment hedging (NIH), as corporates seek to capitalise on favourable interest rate differentials by protecting the value of their foreign assets and locking in carry gains.
NIH serves to shield the reported value of foreign assets from currency fluctuations within accounting statements. For US companies, hedging investments in countries with higher interest rates has traditionally come at a premium.
However, with the US Federal Reserve continuing to raise overnight rates, the cost-benefit calculus is shifting, prompting increased adoption of NIH strategies across the corporate sector.
Also Read
- U.S. Prosecutors Investigate Binance’s Potential Iran Sanctions Violations
- GBP/USD Stalls as Rate‑Hike Bets Dwindle After Oil Decline
- Animoca Brands Pauses IPO Plans, Halts Reverse Merger Discussions with Currenc Group
- Market Conditions Prompt Animoca Brands and Currenc Group to Suspend Reverse Merger


